skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
Tanomastat (Code C1705)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Tanomastat

Definition: A biphenyl matrix metalloproteinase (MMP) inhibitor (MMPI) with potential antineoplastic activity. Tanomastat inhibits MMP-2, MMP-3, and MMP-9, inhibiting extracellular matrix degradation and potentially inhibiting angiogenesis, tumor growth and invasion, and metastasis. MMPs consist of at least 18 zinc-containing endo-proteinases that are capable of degrading collagen and proteoglycan.

NCI-GLOSS Definition: An anticancer drug that belongs to the family of drugs called angiogenesis inhibitors.

Label: Tanomastat

NCI Thesaurus Code: C1705 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0393069  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
(S)-3-[(4'-Chloro-4-biphenylyl)carbonyl]-2-[(phenylthio)methyl]propionic acid
4-[4-(chlorophenyl)phenyl]-4-oxo-2S-(phenylthiomethyl) butanoic acid
BAY 12-9566

External Source Codes: 
CAS Registry Number 179545-77-8 (see NLM ChemIDplus info)
PDQ Closed Trial Search ID 42675
PDQ Open Trial Search ID 42675 (check for NCI PDQ open clinical trial info)
PubMedID Primary Reference 16442153 (see PubMed Primary Reference info)
UMLS CUI C0393069

Other Properties:
     Name Value (qualifiers indented underneath)
Chemical_Formula C23H19ClO3S
code C1705
Contributing_Source FDA
Legacy_Concept_Name Tanomastat
Semantic_Type Organic Chemical
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom